ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV and AIDS Vaccine Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-17L17658
Home | Market Reports | Health| Reproductive Health
Global HIV and AIDS Vaccine Market Research Report 2024
BUY CHAPTERS

Global HIV and AIDS Vaccine Market Research Report 2024

Code: QYRE-Auto-17L17658
Report
June 2024
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vendors
Johnson and Johnson
Johnson and Johnson (Janssen)
Sanofi Pasteur
Uvax Bio
IAVI
AELIX Therapeutics
HKUMed

HIV and AIDS Vaccine Market

The global HIV and AIDS Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for HIV and AIDS Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HIV and AIDS Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of HIV and AIDS Vaccine include Johnson and Johnson (Janssen), Sanofi-Pasteur, Uvax Bio, AELIX Therapeutics, IAVI, HKUMed, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HIV and AIDS Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV and AIDS Vaccine.
The HIV and AIDS Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HIV and AIDS Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV and AIDS Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HIV and AIDS Vaccine Market Report

Report Metric Details
Report Name HIV and AIDS Vaccine Market
Segment by Type
  • Preventive Vaccine
  • Therapeutic Vaccine
Segment by Application
  • Viral Vector Vaccines
  • Recombinant Protein Vaccines
  • Nucleic Acid Vaccines (including mRNA Vaccines)
  • Other Vaccines
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson and Johnson (Janssen), Sanofi-Pasteur, Uvax Bio, AELIX Therapeutics, IAVI, HKUMed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HIV and AIDS Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HIV and AIDS Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the HIV and AIDS Vaccine Market report?

Ans: The main players in the HIV and AIDS Vaccine Market are Johnson and Johnson (Janssen), Sanofi-Pasteur, Uvax Bio, AELIX Therapeutics, IAVI, HKUMed

What are the Application segmentation covered in the HIV and AIDS Vaccine Market report?

Ans: The Applications covered in the HIV and AIDS Vaccine Market report are Viral Vector Vaccines, Recombinant Protein Vaccines, Nucleic Acid Vaccines (including mRNA Vaccines), Other Vaccines

What are the Type segmentation covered in the HIV and AIDS Vaccine Market report?

Ans: The Types covered in the HIV and AIDS Vaccine Market report are Preventive Vaccine, Therapeutic Vaccine

1 HIV and AIDS Vaccine Market Overview
1.1 Product Definition
1.2 HIV and AIDS Vaccine by Type
1.2.1 Global HIV and AIDS Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Preventive Vaccine
1.2.3 Therapeutic Vaccine
1.3 HIV and AIDS Vaccine by Application
1.3.1 Global HIV and AIDS Vaccine Market Value by Application (2024-2030)
1.3.2 Viral Vector Vaccines
1.3.3 Recombinant Protein Vaccines
1.3.4 Nucleic Acid Vaccines (including mRNA Vaccines)
1.3.5 Other Vaccines
1.4 Global HIV and AIDS Vaccine Market Size Estimates and Forecasts
1.4.1 Global HIV and AIDS Vaccine Revenue 2019-2030
1.4.2 Global HIV and AIDS Vaccine Sales 2019-2030
1.4.3 Global HIV and AIDS Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HIV and AIDS Vaccine Market Competition by Manufacturers
2.1 Global HIV and AIDS Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global HIV and AIDS Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HIV and AIDS Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of HIV and AIDS Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HIV and AIDS Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV and AIDS Vaccine, Product Type & Application
2.7 Global Key Manufacturers of HIV and AIDS Vaccine, Date of Enter into This Industry
2.8 Global HIV and AIDS Vaccine Market Competitive Situation and Trends
2.8.1 Global HIV and AIDS Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HIV and AIDS Vaccine Players Market Share by Revenue
2.8.3 Global HIV and AIDS Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HIV and AIDS Vaccine Market Scenario by Region
3.1 Global HIV and AIDS Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HIV and AIDS Vaccine Sales by Region: 2019-2030
3.2.1 Global HIV and AIDS Vaccine Sales by Region: 2019-2024
3.2.2 Global HIV and AIDS Vaccine Sales by Region: 2025-2030
3.3 Global HIV and AIDS Vaccine Revenue by Region: 2019-2030
3.3.1 Global HIV and AIDS Vaccine Revenue by Region: 2019-2024
3.3.2 Global HIV and AIDS Vaccine Revenue by Region: 2025-2030
3.4 North America HIV and AIDS Vaccine Market Facts & Figures by Country
3.4.1 North America HIV and AIDS Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HIV and AIDS Vaccine Sales by Country (2019-2030)
3.4.3 North America HIV and AIDS Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV and AIDS Vaccine Market Facts & Figures by Country
3.5.1 Europe HIV and AIDS Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HIV and AIDS Vaccine Sales by Country (2019-2030)
3.5.3 Europe HIV and AIDS Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV and AIDS Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific HIV and AIDS Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HIV and AIDS Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific HIV and AIDS Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV and AIDS Vaccine Market Facts & Figures by Country
3.7.1 Latin America HIV and AIDS Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HIV and AIDS Vaccine Sales by Country (2019-2030)
3.7.3 Latin America HIV and AIDS Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HIV and AIDS Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV and AIDS Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HIV and AIDS Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa HIV and AIDS Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV and AIDS Vaccine Sales by Type (2019-2030)
4.1.1 Global HIV and AIDS Vaccine Sales by Type (2019-2024)
4.1.2 Global HIV and AIDS Vaccine Sales by Type (2025-2030)
4.1.3 Global HIV and AIDS Vaccine Sales Market Share by Type (2019-2030)
4.2 Global HIV and AIDS Vaccine Revenue by Type (2019-2030)
4.2.1 Global HIV and AIDS Vaccine Revenue by Type (2019-2024)
4.2.2 Global HIV and AIDS Vaccine Revenue by Type (2025-2030)
4.2.3 Global HIV and AIDS Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global HIV and AIDS Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global HIV and AIDS Vaccine Sales by Application (2019-2030)
5.1.1 Global HIV and AIDS Vaccine Sales by Application (2019-2024)
5.1.2 Global HIV and AIDS Vaccine Sales by Application (2025-2030)
5.1.3 Global HIV and AIDS Vaccine Sales Market Share by Application (2019-2030)
5.2 Global HIV and AIDS Vaccine Revenue by Application (2019-2030)
5.2.1 Global HIV and AIDS Vaccine Revenue by Application (2019-2024)
5.2.2 Global HIV and AIDS Vaccine Revenue by Application (2025-2030)
5.2.3 Global HIV and AIDS Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global HIV and AIDS Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson and Johnson (Janssen)
6.1.1 Johnson and Johnson (Janssen) Company Information
6.1.2 Johnson and Johnson (Janssen) Description and Business Overview
6.1.3 Johnson and Johnson (Janssen) HIV and AIDS Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson and Johnson (Janssen) HIV and AIDS Vaccine Product Portfolio
6.1.5 Johnson and Johnson (Janssen) Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Company Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur HIV and AIDS Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur HIV and AIDS Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Uvax Bio
6.3.1 Uvax Bio Company Information
6.3.2 Uvax Bio Description and Business Overview
6.3.3 Uvax Bio HIV and AIDS Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Uvax Bio HIV and AIDS Vaccine Product Portfolio
6.3.5 Uvax Bio Recent Developments/Updates
6.4 AELIX Therapeutics
6.4.1 AELIX Therapeutics Company Information
6.4.2 AELIX Therapeutics Description and Business Overview
6.4.3 AELIX Therapeutics HIV and AIDS Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AELIX Therapeutics HIV and AIDS Vaccine Product Portfolio
6.4.5 AELIX Therapeutics Recent Developments/Updates
6.5 IAVI
6.5.1 IAVI Company Information
6.5.2 IAVI Description and Business Overview
6.5.3 IAVI HIV and AIDS Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 IAVI HIV and AIDS Vaccine Product Portfolio
6.5.5 IAVI Recent Developments/Updates
6.6 HKUMed
6.6.1 HKUMed Company Information
6.6.2 HKUMed Description and Business Overview
6.6.3 HKUMed HIV and AIDS Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HKUMed HIV and AIDS Vaccine Product Portfolio
6.6.5 HKUMed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV and AIDS Vaccine Industry Chain Analysis
7.2 HIV and AIDS Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV and AIDS Vaccine Production Mode & Process
7.4 HIV and AIDS Vaccine Sales and Marketing
7.4.1 HIV and AIDS Vaccine Sales Channels
7.4.2 HIV and AIDS Vaccine Distributors
7.5 HIV and AIDS Vaccine Customers
8 HIV and AIDS Vaccine Market Dynamics
8.1 HIV and AIDS Vaccine Industry Trends
8.2 HIV and AIDS Vaccine Market Drivers
8.3 HIV and AIDS Vaccine Market Challenges
8.4 HIV and AIDS Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Vendors
Johnson and Johnson
Johnson and Johnson (Janssen)
Sanofi Pasteur
Uvax Bio
IAVI
AELIX Therapeutics
HKUMed
List of Tables
 Table 1. Global HIV and AIDS Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global HIV and AIDS Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global HIV and AIDS Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global HIV and AIDS Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global HIV and AIDS Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global HIV and AIDS Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global HIV and AIDS Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market HIV and AIDS Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of HIV and AIDS Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HIV and AIDS Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HIV and AIDS Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of HIV and AIDS Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HIV and AIDS Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HIV and AIDS Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global HIV and AIDS Vaccine Sales by Region (2019-2024) & (K Units)
 Table 18. Global HIV and AIDS Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global HIV and AIDS Vaccine Sales by Region (2025-2030) & (K Units)
 Table 20. Global HIV and AIDS Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global HIV and AIDS Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global HIV and AIDS Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global HIV and AIDS Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global HIV and AIDS Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America HIV and AIDS Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America HIV and AIDS Vaccine Sales by Country (2019-2024) & (K Units)
 Table 27. North America HIV and AIDS Vaccine Sales by Country (2025-2030) & (K Units)
 Table 28. North America HIV and AIDS Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America HIV and AIDS Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe HIV and AIDS Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe HIV and AIDS Vaccine Sales by Country (2019-2024) & (K Units)
 Table 32. Europe HIV and AIDS Vaccine Sales by Country (2025-2030) & (K Units)
 Table 33. Europe HIV and AIDS Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe HIV and AIDS Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific HIV and AIDS Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific HIV and AIDS Vaccine Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific HIV and AIDS Vaccine Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific HIV and AIDS Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific HIV and AIDS Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America HIV and AIDS Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America HIV and AIDS Vaccine Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America HIV and AIDS Vaccine Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America HIV and AIDS Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America HIV and AIDS Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa HIV and AIDS Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa HIV and AIDS Vaccine Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa HIV and AIDS Vaccine Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa HIV and AIDS Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa HIV and AIDS Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global HIV and AIDS Vaccine Sales (K Units) by Type (2019-2024)
 Table 51. Global HIV and AIDS Vaccine Sales (K Units) by Type (2025-2030)
 Table 52. Global HIV and AIDS Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global HIV and AIDS Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global HIV and AIDS Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global HIV and AIDS Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global HIV and AIDS Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global HIV and AIDS Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global HIV and AIDS Vaccine Price (US$/Unit) by Type (2019-2024)
 Table 59. Global HIV and AIDS Vaccine Price (US$/Unit) by Type (2025-2030)
 Table 60. Global HIV and AIDS Vaccine Sales (K Units) by Application (2019-2024)
 Table 61. Global HIV and AIDS Vaccine Sales (K Units) by Application (2025-2030)
 Table 62. Global HIV and AIDS Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global HIV and AIDS Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global HIV and AIDS Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global HIV and AIDS Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global HIV and AIDS Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global HIV and AIDS Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global HIV and AIDS Vaccine Price (US$/Unit) by Application (2019-2024)
 Table 69. Global HIV and AIDS Vaccine Price (US$/Unit) by Application (2025-2030)
 Table 70. Johnson and Johnson (Janssen) Company Information
 Table 71. Johnson and Johnson (Janssen) Description and Business Overview
 Table 72. Johnson and Johnson (Janssen) HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Johnson and Johnson (Janssen) HIV and AIDS Vaccine Product
 Table 74. Johnson and Johnson (Janssen) Recent Developments/Updates
 Table 75. Sanofi-Pasteur Company Information
 Table 76. Sanofi-Pasteur Description and Business Overview
 Table 77. Sanofi-Pasteur HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sanofi-Pasteur HIV and AIDS Vaccine Product
 Table 79. Sanofi-Pasteur Recent Developments/Updates
 Table 80. Uvax Bio Company Information
 Table 81. Uvax Bio Description and Business Overview
 Table 82. Uvax Bio HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Uvax Bio HIV and AIDS Vaccine Product
 Table 84. Uvax Bio Recent Developments/Updates
 Table 85. AELIX Therapeutics Company Information
 Table 86. AELIX Therapeutics Description and Business Overview
 Table 87. AELIX Therapeutics HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. AELIX Therapeutics HIV and AIDS Vaccine Product
 Table 89. AELIX Therapeutics Recent Developments/Updates
 Table 90. IAVI Company Information
 Table 91. IAVI Description and Business Overview
 Table 92. IAVI HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. IAVI HIV and AIDS Vaccine Product
 Table 94. IAVI Recent Developments/Updates
 Table 95. HKUMed Company Information
 Table 96. HKUMed Description and Business Overview
 Table 97. HKUMed HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. HKUMed HIV and AIDS Vaccine Product
 Table 99. HKUMed Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. HIV and AIDS Vaccine Distributors List
 Table 103. HIV and AIDS Vaccine Customers List
 Table 104. HIV and AIDS Vaccine Market Trends
 Table 105. HIV and AIDS Vaccine Market Drivers
 Table 106. HIV and AIDS Vaccine Market Challenges
 Table 107. HIV and AIDS Vaccine Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HIV and AIDS Vaccine
 Figure 2. Global HIV and AIDS Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global HIV and AIDS Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Preventive Vaccine Product Picture
 Figure 5. Therapeutic Vaccine Product Picture
 Figure 6. Global HIV and AIDS Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global HIV and AIDS Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Viral Vector Vaccines
 Figure 9. Recombinant Protein Vaccines
 Figure 10. Nucleic Acid Vaccines (including mRNA Vaccines)
 Figure 11. Other Vaccines
 Figure 12. Global HIV and AIDS Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global HIV and AIDS Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 14. Global HIV and AIDS Vaccine Sales (2019-2030) & (K Units)
 Figure 15. Global HIV and AIDS Vaccine Average Price (US$/Unit) & (2019-2030)
 Figure 16. HIV and AIDS Vaccine Report Years Considered
 Figure 17. HIV and AIDS Vaccine Sales Share by Manufacturers in 2023
 Figure 18. Global HIV and AIDS Vaccine Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest HIV and AIDS Vaccine Players: Market Share by Revenue in HIV and AIDS Vaccine in 2023
 Figure 20. HIV and AIDS Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global HIV and AIDS Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America HIV and AIDS Vaccine Sales Market Share by Country (2019-2030)
 Figure 23. North America HIV and AIDS Vaccine Revenue Market Share by Country (2019-2030)
 Figure 24. United States HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe HIV and AIDS Vaccine Sales Market Share by Country (2019-2030)
 Figure 27. Europe HIV and AIDS Vaccine Revenue Market Share by Country (2019-2030)
 Figure 28. Germany HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific HIV and AIDS Vaccine Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific HIV and AIDS Vaccine Revenue Market Share by Region (2019-2030)
 Figure 35. China HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America HIV and AIDS Vaccine Sales Market Share by Country (2019-2030)
 Figure 43. Mexico HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa HIV and AIDS Vaccine Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa HIV and AIDS Vaccine Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE HIV and AIDS Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of HIV and AIDS Vaccine by Type (2019-2030)
 Figure 53. Global Revenue Market Share of HIV and AIDS Vaccine by Type (2019-2030)
 Figure 54. Global HIV and AIDS Vaccine Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of HIV and AIDS Vaccine by Application (2019-2030)
 Figure 56. Global Revenue Market Share of HIV and AIDS Vaccine by Application (2019-2030)
 Figure 57. Global HIV and AIDS Vaccine Price (US$/Unit) by Application (2019-2030)
 Figure 58. HIV and AIDS Vaccine Value Chain
 Figure 59. HIV and AIDS Vaccine Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global HIV Vaccine Market Research Report 2025
Global HIV and AIDS Clinical Trials Market Research Report 2025
Global Adult Vaccines Market Research Report 2024
Global HIV Clinical Trials Market Research Report 2025
Global HIV Prevention Drug Market Research Report 2024
Global Multiple Vaccine Market Research Report 2024
Global Vaccines for the Elderly Market Research Report 2024
Global Viral Arthritis Vaccine Market Research Report 2025
Global Human Immunodeficiency Virus Type 1 Market Research Report 2024
Global Artificial Intelligence AI in HIV and AIDS Market Research Report 2024
Global Vaccines For Cattle And Sheep Market Research Report 2024
Global Biopharmaceutical and Vaccines Market Research Report 2024
Global Monkeypox Virus Vaccine Market Research Report 2024
Global Harvest Aids Market Research Report 2025
Global Adult and Pediatric Vaccines Market Research Report 2024
Global Anti AIDs Drug Market Insights Forecast to 2030
Human Vaccine Adjuvants Market
Global Seasonal Vaccines Market Research Report 2024
Global HIV 1 Screening Tests Market Research Report 2025
Global Health Product for Immune Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions